PRENETICS GLOBAL LTD PRE
SHS NEW · Common Stock · CUSIP G72245122
- SectorHealth care
- IndustryPharmaceutical Preparations
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $5.92. Options: 1 managers hold calls ($474.8k notional), 0 hold puts (—).
Trends to Q2 2024
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q4 2023 | 6 |
| Q1 2024 | 9 |
| Q2 2024 | 8 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q1 2024 | 4 | 0 |
| Q2 2024 | 1 | 2 |
Calls vs puts
Options held, notional value, last 4 quarters. P/C = puts ÷ calls
Numbers
| Quarter | Calls | Puts | P/C |
|---|---|---|---|
| Q3 2023 | $0 | $0 | — |
| Q4 2023 | $477.3k | $0 | 0.00 |
| Q1 2024 | $324.9k | $0 | 0.00 |
| Q2 2024 | $474.8k | $0 | 0.00 |
Biggest buyers
| UBS Group AG | Added | +38.8k |
Biggest sellers
| PRUDENTIAL PLC | Reduced | -201.9k |
| OSAIC HOLDINGS, INC. | Sold out | -450 |
Biggest calls
| Paloma Partners Management Co | Unchanged | $474.8k80.2k shares |
Biggest puts
| None |
Options at notional value: the value of the shares the contracts control, as filers report them, not what the options cost. Not included in the holders, shares or buying above.
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
No one currently above 5% in the filings since 19 Dec 2024.
Fell to 5% or below in the last year: Genetel Bioventures Ltd (3.3%, 2026-04-22)
Insider purchases and sales in Q2 2024
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
None reported in Q2 2024.
Holders, Q2 2024
| Manager | Shares | Change |
|---|---|---|
| PRUDENTIAL PLC 0.02% of their portfolio | 483.0k $2.9m | Reduced -201.9k |
| Aspex Management (HK) Ltd 0.04% of their portfolio | 346.1k $2.0m | Unchanged |
| NOMURA HOLDINGS INC 0.01% of their portfolio | 323.0k $1.9m | Unchanged |
| UBS Group AG 0.00% of their portfolio | 40.1k $237.3k | Added +38.8k |
| Aspire Private Capital, LLC 0.00% of their portfolio | 114 $675 | Unchanged |
| BANK OF AMERICA CORP /DE/ 0.00% of their portfolio | 111 $657 | Unchanged |
| WOLVERINE ASSET MANAGEMENT LLC 0.00% of their portfolio | 1 $5 | Unchanged |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | Unchanged |